Overview of Transaction

• On August 13, 2024, Experian (LSE: EXPN) announced that it completed the acquisition of NeuroID
• Founded in 2014, NeuroID is a leading behavioral analytics platform that combines behavior, device and network intelligence to detect and stop fraud
• Digital businesses use NeuroID to provide deep visibility into digital interactions (without collecting personal data) to proactively monitor, alert and act against fraud
• NeuroID accelerates risk management so global leaders can see fraud faster, reduce losses and increase savings
• Experian is a global data and technology company, powering opportunities for people and businesses around the world
• Experian helps to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions and gain deeper insights into the automotive market, all using a unique combination of data, analytics and software

Significance of Transaction

• With the acquisition, NeuroID will become available through CrossCore® on Experian’s Ascend Technology Platform as a key fraud-detection capability
• With NeuroID integrated into Experian, clients can use one service provider to proactively monitor and analyze a user’s real-time digital behavior
• NeuroID’s modern and frictionless capabilities amplify Experian’s fraud risk suite by providing a new layer of insight into digital behavioral signals and analytics observed for both new and returning users throughout the customer lifecycle, including account openings, logins and transactions

FT Partners' Role

• FT Partners served as the exclusive financial and strategic advisor to NeuroID
• This transaction underscores FT Partners’ position as the leading advisor to FinTech companies globally as well as its ability to generate positive outcomes across the Fraud Prevention, Risk and Data Analytics space